Literature DB >> 17070168

Force- and relaxation-frequency relations in patients with diastolic heart failure.

Takashi Yamanaka1, Katsuya Onishi, Masaki Tanabe, Kaoru Dohi, Kaoru Funabiki-Yamanaka, Naoki Fujimoto, Tairo Kurita, Takashi Tanigawa, Tetsuya Kitamura, Masaaki Ito, Tsutomu Nobori, Takeshi Nakano.   

Abstract

BACKGROUND: Chronotropic effects on myocardial contractility (the positive force-frequency relation) and relaxation (the positive relaxation-frequency relation) are impaired in patients with congestive heart failure and depressed left ventricular (LV) ejection fraction (systolic heart failure [SHF]). However, the force- and relaxation-frequency relation and LV-arterial coupling in patients with diastolic heart failure (DHF) has not been fully investigated. METHODS AND
RESULTS: To examine inotropic and lusitropic responsiveness to atrial pacing, LV pressure-volume relations were measured using a conductance catheter and microtip manometer in patients with DHF (n = 18) and SHF (n = 11). In patients with SHF, an increase in heart rate by 40 beat/min did not affect LV end-systolic elastance (Ees), which reflects LV contractility, or the time constant of LV relaxation. By contrast, in patients with DHF, an increase in heart rate by 40 beat/min significantly enhanced Ees (2.1 vs 2.9 mm Hg/mL, P < .05) but not the time constant. Furthermore, LV-arterial coupling, quantified as Ees/arterial elastance, was impaired during pacing in patients with DHF (1.1 vs 0.8, P < .05) as well as SHF.
CONCLUSIONS: In patients with DHF, the force-frequency relation was preserved, but the relaxation-frequency relation was impaired. Furthermore, LV-arterial coupling was impaired as heart rate increased, which may be related to the impaired LV function. These results suggest that the impaired relaxation-frequency relation and exacerbated LV-arterial coupling during tachycardia may be an important therapeutic target in patients with DHF.

Entities:  

Mesh:

Year:  2006        PMID: 17070168     DOI: 10.1016/j.ahj.2006.06.023

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  Two-dimensional strain or strain rate findings in mild to moderate diastolic dysfunction with preserved ejection fraction.

Authors:  Hyungseop Kim; Hong-Won Shin; Jihyun Son; Hyuck-Jun Yoon; Hyoung-Seob Park; Yun-Kyeong Cho; Chun-Duk Han; Chang-Wook Nam; Seung-Ho Hur; Yoon-Nyun Kim; Kwon-Bae Kim
Journal:  Heart Vessels       Date:  2010-10-27       Impact factor: 2.037

2.  A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Authors:  Tomoyuki Watanabe; Masumi Iwai-Takano; Hiromi Saitoh; Kohko Kanazawa; Takashi Igarashi; Tsuyoshi Fujimiya; Tetsuya Ohira
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

3.  Prognostic value of left-ventricular and peripheral vascular performance in patients with dilated cardiomyopathy.

Authors:  Tonino Bombardini; Edoardo Nevola; Assuero Giorgetti; Patrizia Landi; Eugenio Picano; Danilo Neglia
Journal:  J Nucl Cardiol       Date:  2008-04-16       Impact factor: 5.952

4.  How to consider target heart rate in patients with systolic heart failure.

Authors:  Toshihide Izumida; Teruhiko Imamura; Makiko Nakamura; Nobuyuki Fukuda; Koichiro Kinugawa
Journal:  ESC Heart Fail       Date:  2020-06-27

5.  Personalized pacing for diastolic dysfunction and heart failure with preserved ejection fraction: Design and rationale for the myPACE randomized controlled trial.

Authors:  Margaret Infeld; Kramer Wahlberg; Jillian Cicero; Sean Meagher; Nicole Habel; Anand Muthu Krishnan; Daniel N Silverman; Daniel L Lustgarten; Markus Meyer
Journal:  Heart Rhythm O2       Date:  2021-12-07

6.  Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure.

Authors:  Rolf Wachter; Stephan Schmidt-Schweda; Dirk Westermann; Heiner Post; Frank Edelmann; Mario Kasner; Claus Lüers; Paul Steendijk; Gerd Hasenfuss; Carsten Tschöpe; Burkert Pieske
Journal:  Eur Heart J       Date:  2009-12       Impact factor: 29.983

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.